Treatment of primary focal hyperhidrosis

Cutis

Volumn 77, Issue 5 SUPPL., 2006, Pages 28-41

  Glaser, Dee Anna ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33744908032     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. James WD, Schoomaker EB, Rodman OG. Emotional eccrine sweating: a heritable disorder. Arch Dermatol. 1987;123:925-929.
2. Leung AKC, Chan PYH, Choi MCK. Hyperhidrosis. Int J Dermatol. 1999;38:561-567.
3. Hornberger J, Grimes K, Naumann M, et al, and the Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51:274-286.
4. Kreyden OP. Rare forms of hyperhidrosis. Curr Probl Dermatol. 2002;30:178-187.
5. Hund M, Kinkelin I, Naumann M, et al. Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol. 2002;138:539-541.
6. Campanati A, Penna L, Guzzo T, et al. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study. Clin Ther. 2003;25:298-308.
7. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216.
8. Minor V. Ein neues Verfahren zu der klinischen Untersuchung der Schweißabsonderung. Dtsch Z Nervenheilkd. 1927;101:302-308.
9. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ. 2001;323:596-599.
10. Naumann MK, Hamm H, Lowe NJ; Botox Hyperhidrosis Clinical Study Group. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol. 2002;147:1218-1226.
11. Strutton DR, Kowalski JW, Glaser DA, et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51:241-248.
12. Swan MC, Paes T. Quality of life evaluation following endoscopic transthoracic sympathectomy for upper limb and facial hyperhydrosis. Ann Chir Gynaecol. 2001;90:157-159.
13. Teale CW, Roberts G, Hamm H, et al. Development, validity, and reliability of the Hyperhidrosis Impact Questionnaire (HHIQ)[abstract]. Qual Life Res. 2002;11:702. Abstract 324.
14. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
15. Solish N. Assessing hyperhidrosis disease severity and impact on quality of life. Cutis. 2006;77(suppl 5):17-27.
16. Atkins JL, Butler PEM. Hyperhidrosis: a review of current management. Plast Reconstr Surg. 2002;110:222-228.
17. Shelley WB, Hurley HJ Jr. Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Derm Venereol. 1975;55:241-260.
18. Benohanian A, Dansereau A, Bolduc C, et al. Localized hyperhidrosis treated with aluminum chloride in a salicylic acid gel base. Int J Dermatol. 1998;37:701-703.
19. Glent-Madsen L, Dahl JC. Axillary hyperhidrosis: local treatment with aluminium-chloride hexahydrate 25% in absolute ethanol with and without supplementary treatment with triethanolamine. Acta Derm Venereol. 1988;68:87-89.
20. Rayner CR, Ritchie ID, Stark GP. Axillary hyperhidrosis, 20% aluminium chloride hexahydrate, and surgery. Br Med J. 1980;280:1168.
21. Scholes KT, Crow KD, Ellis JP, et al. Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate. Br Med J. 1978;2:84-85.
22. Jensen O, Karlsmark T. Palmoplantar hyperhidrosis: treatment with alcohol solution of aluminium chloride hexahydrate: a simple method of transpiration measurement. Dermatologica. 1980;161:133-135.
23. Hölzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution. Br J Dermatol. 1984;110:399-403.
24. Abell E, Morgan K. The treatment of idiopathic hyperhidrosis by glycopyrronium bromide and tap water iontophoresis. Br J Dermatol. 1974;91:87-91.
25. Grice K, Sattar H, Baker H. Treatment of idiopathic hyperhidrosis with iontophoresis of tap water and poldine methosulphate. Br J Dermatol. 1972;86:72-78.
26. Shen J-L, Lin G-S, Li W-M. A new strategy of iontophoresis for hyperhidrosis. J Am Acad Dermatol. 1990;22:239-241.
27. Dahl JC, Glent-Madsen L. Treatment of hyperhidrosis manuum by tap water iontophoresis. Acta Derm Venereol. 1989;69:346-348.
28. Reinauer S, Neusser A, Schauf G, et al. Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis. Br J Dermatol. 1993;129:166-169.
29. Stolman LP. Treatment of excess sweating of the palms by iontophoresis. Arch Dermatol. 1987;123:893-896.
30. Akins DL, Meisenheimer JL, Dobson RL. Efficacy of the Drionic unit in the treatment of hyperhidrosis. J Am Acad Dermatol. 1987;16:828-832.
31. Bouman HD, Lentzer EMG. The treatment of hyperhidrosis of hands and feet with constant current. Am J Phys Med. 1952;31:158-169.
32. Shrivastava SN, Singh G. Tap water iontophoresis in palmo-plantar hyperhidrosis. Br J Dermatol. 1977;96:189-195.
33. Bushara KO, Park DM, Jones JC, et al. Botulinum toxin-a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol. 1996;21:276-278.
34. Glaser DA, Lowe NJ, Eadie N, et al. 52-week prospective randomized double-blind placebo-controlled safety and efficacy study of 2 dosages of botulinum toxin type A treatment for primary axillary hyperhidrosis. Poster presented at: American Academy of Neurology 56th Annual Meeting; April 24-May 1, 2004; San Francisco, Calif. P04-0258.
35. Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis: no sweat Botox. Dermatol Surg. 1998;24:817-819.
36. Heckmann M, Breit S, Ceballos-Baumann A, et al. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol. 1999;41:987-990.
37. Heckmann M, Ceballos-Baumann AO, Plewig G, and the Hyperhidrosis Study Group. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344:488-493.
38. Naver H, Swartling C, Aquilonius S-M. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up. Eur J Neurol. 2000;7:55-62.
39. Odderson IR. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis. Dermatol Surg. 2002;28:480-483.
40. Salmanpoor R, Rahmanian MJ. Treatment of axillary hyperhidrosis with botulinum-A toxin. Int J Dermatol. 2002;41:428-430.
41. Schnider P, Binder M, Kittler H, et al. A randomized double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis. Br J Dermatol. 1999;140:677-680.
42. Sinclair MT, Russell W, Toosey N, et al. Prospective double blind randomized controlled trial of botulinum toxin A in axillary hyperhidrosis. Br J Surg. 2001;88(suppl 1):80.
43. Tan SR, Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg. 2002;28:495-499.
44. Whatling PJ, Collin J. Botulinum toxin injection is an effective treatment for axillary hyperhidrosis. Br J Surg. 2001;88:814-815.
45. Wollina U, Karamfilov T, Konrad H. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol. 2002;46:536-540.
46. Lowe NJ, Yamauchi PS, Lask GP, et al. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg. 2002;28:822-827.
47. Naumann M, Hofmann U, Bergmann I, et al. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol. 1998;134:301-304.
48. Naver H, Swartling C, Aquilonius S-M. Treatment of focal hyperhidrosis with botulinum toxin type A: brief overview of methodology and 2 years' experience. Eur J Neurol. 1999;6(suppl 4):S117-S120.
49. Saadia D, Voustianiouk A, Wang AK, et al. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study. Neurology. 2001;57:2095-2099.
50. Schnider P, Moraru E, Kittler H, et al. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol. 2001;145:289-293.
51. Schnider P, Binder M, Auff E, et al. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol. 1997;136:548-552.
52. Solomon BA, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol. 2000;42:1026-1029.
53. Vadoud-Seyedi J, Heenen M, Simonart T. Treatment of idiopathic palmar hyperhidrosis with botulinum toxin: report of 23 cases and review of the literature. Dermatology. 2001;203:318-321.
54. Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol 2001;8:247-252.
55. Vadoud-Seyedi J. Treatment of plantar hyperhidrosis with botulinum toxin type A. Int J Dermatol. 2004;43:969-971.
56. Böger A, Herath H, Rompel R, et al. Botulinum toxin for treatment of craniofacial hyperhidrosis. J Neurol. 2000;247:857-861.
57. Kinkelin I, Hund M, Naumann M, et al. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol. 2000;143:824-827.
58. Kavanagh GM, Oh C, Shams K. BOTOX delivery by iontophoresis. Br J Dermatol. 2004;151:1093-1095.
59. Vadoud-Seyedi J, Simonart T, Heenen M. Treatment of plantar hyperhidrosis with Dermojet injections of botulinum toxin [letter]. Dermatology. 2000;201:179.
60. Baumann LS, Halem ML. Systemic adverse effects after botulinum toxin type B (Myobloc) injections for the treatment of palmar hyperhidrosis. Arch Dermatol. 2003;139:226-227.
61. Dressler D, Adib Saberi F, Benecke R. Botulinum toxin type B for treatment of axillar hyperhidrosis. J Neurol. 2002;249:1729-1732.
62. Hecht MJ, Birklein F, Winterholler M. Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study. Arch Dermatol Res. 2004;295:318-319.
63. Nelson L, Bachoo P, Holmes J. Botulinum toxin type B: a new therapy for axillary hyperhidrosis. Br J Plast Surg. 2005;58:228-232.
64. Borges AF. For axillary hyperhidrosis, W-plastic fusiform incision. Va Med. 1981;108:550-552.
65. Breach NM. Axillary hyperhidrosis: surgical cure with aesthetic scars. Ann R Coll Surg Engl. 1979;61:295-297.
66. Moran KT, Brady MP. Surgical management of primary hyperhidrosis. Br J Surg. 1991;78:279-283.
67. Lillis PJ, Coleman WP III. Liposuction for treatment of axillary hyperhidrosis. Dermatol Clin. 1990;8:479-482.
68. Shenaq SM, Spira M. Treatment of bilateral axillary hyperhidrosis by suction-assisted lipolysis technique. Ann Plast Surg. 1987;19:548-551.
69. Rompel R, Scholz S. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol. 2001;15:207-211.
70. Lin T-S, Wang N-P, Huang L-C. Pitfalls and complication avoidance associated with transthoracic endoscopic sympathectomy for primary hyperhidrosis (analysis of 2200 cases). Int J Surg Investig. 2001;2:377-385.
71. Herbst F, Plas EG, Függer R, et al. Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbs: a critical analysis and long-term results of 480 operations. Ann Surg. 1994;220:86-90.
72. Zacherl J, Huber ER, Imhof M, et al. Long-term results of 630 thoracoscopic sympathicotomies for primary hyperhidrosis: the Vienna experience. Eur J Surg Suppl. 1998;580:43-46.
73. Lee KH, Hwang PY. Video endoscopic sympathectomy for palmar hyperhidrosis. J Neurosurg. 1996;84:484-486.
74. Chuang K-S, Liu J-C. Long-term assessment of percutaneous stereotactic thermocoagulation of upper thoracic ganglionectomy and sympathectomy for palmar and craniofacial hyperhidrosis in 1742 cases. Neurosurgery. 2002;51:963-970.